National Association of Testing Authorities, Australia
Scope of Accreditation
PathWest Laboratory Medicine WA
Site
Fiona Stanley Hospital
Accreditation No.
2392
Site No.
22309
Date of Accreditation
19 May 2015
Contact
Ms Milana Ranieri P: +61 (08) 64571937
Availability
Services available to external clients
Supervision
GX (General)
Scope of Accreditation
Acute Ward
ISO 15189 (2022)
Human Pathology
Medicare expiry date
04 Aug 2026
Last Activity Date
07 Mar 2024
| Service | Product | Determinant |
|---|---|---|
| Chemical pathology - Quantitation of blood gases and other measurements (performed on the same specimen) | Blood | Anion gap; Base excess; Calcium; Carboxyhaemoglobin; Chloride; Creatinine; Deoxyhaemoglobin (HHb); Glucose; Lactate; Partial pressure of carbon dioxide (pCO2); Partial pressure of oxygen (PO2); Potassium; Sodium; pH |
Angiography
ISO 15189 (2022)
Human Pathology
Medicare expiry date
04 Aug 2026
Last Activity Date
07 Mar 2024
| Service | Product | Determinant |
|---|---|---|
| Chemical pathology - Quantitation of blood gases and other measurements (performed on the same specimen) | Blood | Anion gap; Base excess; Calcium; Carboxyhaemoglobin; Chloride; Deoxyhaemoglobin (HHb); Glucose; Lactate; Partial pressure of carbon dioxide (pCO2); Partial pressure of oxygen (PO2); Potassium; Sodium; pH |
Biochemistry Department
ISO 15189 (2022)
Human Pathology
Medicare expiry date
04 Aug 2026
Last Activity Date
07 Mar 2024
| Service | Product | Determinant |
|---|---|---|
| Chemical pathology - Analysis of drugs for toxicological (non-legal) purposes and ingested or absorbed toxic chemicals | Plasma | Ethanol |
| Chemical pathology - Detection and/or quantitation of drugs for therapeutic monitoring | Plasma; Serum | Amikacin; Carbamazepine; Cyclosporin; Digoxin; Gentamicin (cidomycin, septopal, genticyn, garamycin); Lithium; Methotrexate; Paracetamol (acetaminophen); Phenytoin (dilantin); Theophylline; Tobramycin; Valproate (valproic acid, epilim); Vancomycin |
| Chemical pathology - Detection and/or quantitation of tumour markers | Ascitic fluid | CA19-9 antigen (CA19-9); Carcinoembryonic antigen (CEA) |
| Bile fluid | CA19-9 antigen (CA19-9) | |
| Cerebrospinal fluid (CSF) | α-Fetoprotein (AFP) | |
| Cyst fluid | CA19-9 antigen (CA19-9); Carcinoembryonic antigen (CEA) | |
| Plasma; Serum | CA125 antigen (CA125); CA15-3 antigen (CA15-3); CA19-9 antigen (CA19-9); Carcinoembryonic antigen (CEA); Prostate specific antigen (PSA); Prostate specific antigen (PSA) fractions and derived index; α-Fetoprotein (AFP) | |
| Pleural fluid | CA19-9 antigen (CA19-9); Carcinoembryonic antigen (CEA) | |
| Chemical pathology - Determination of hormones and hormone binding proteins (other than thyroid function tests) | Plasma | C-peptide; Cortisol; Follicle stimulating hormone (FSH); Insulin; Luteinising hormone (LH); Macroprolactin; Oestradiol; Parathyroid hormone (PTH); Procalcitonin; Progesterone; Prolactin; Testosterone |
| Chemical pathology - Further investigation of cardiac function | Plasma; Serum | Troponin I |
| Chemical pathology - Further investigation of lipid profiles for diagnosis of types III and IV hyperlipidaemia | Plasma | Apolipoprotein A; Apolipoprotein B; HDL - Quantitation; Lipoprotein subclasses |
| Chemical pathology - Further investigation of renal and/or hepatic function | Plasma | α1-Antitrypsin |
| Plasma; Urine | Caeruloplasmin; Haptoglobins; Uric acid | |
| Chemical pathology - Haem related pigments and precursors (excluding porphyria) | Cerebrospinal fluid (CSF) | Bilirubin; Methaemalbumin; Methaemoglobin (MetHb); Oxyhaemoglobin |
| Chemical pathology - Investigation and determination of hepatic, cardiac, bone, skeletal muscle and other profiles and metabolic studies | Ascitic fluid | Albumin; Amylase; Cholesterol - LDL; Creatinine; Glucose; Lactate dehydrogenase (LDH); Lipase; Potassium; Protein - Total; Sodium; Triglycerides |
| Cerebrospinal fluid (CSF) | Glucose; Lactate dehydrogenase (LDH); Protein - Total | |
| Lactate | ||
| Cyst fluid | Amylase; Lipase | |
| Drainage fluid | Amylase; Creatinine; Lipase | |
| Other body fluidsBile fluid to be added to masterlist and then "other body fluids" removed. | Bilirubin - Total | |
| Plasma; Serum | Alanine aminotransferase; Albumin; Alkaline phosphatase; Ammonia; Amylase; Bicarbonate; Bilirubin - Any fractions; Bilirubin - Total; C-reactive protein (CRP); Calcium - Corrected for albumin; Calcium - Total; Chloride; Cholesterol - LDL; Creatine kinase; Creatinine; Glucose; Lactate dehydrogenase (LDH); Lipase; Magnesium; Phosphate; Potassium; Protein - Total; Sodium; Triglycerides; Urea; γ-Glutamyltransferase | |
| Plasma; Serum; Urine | Osmolality | |
| Pleural fluid | Albumin; Amylase; Cholesterol - LDL; Creatinine; Glucose; Lactate dehydrogenase (LDH); Lipase; Potassium; Protein - Total; Sodium; Triglycerides | |
| Urine | Albumin; Amylase; Calcium - Total; Chloride; Creatinine; Magnesium; Phosphorus; Potassium; Protein - Total; Sodium; Urea; Uric acid | |
| Chemical pathology - Iron studies | Plasma | Ferritin; Iron; Transferrin |
| Chemical pathology - Quantitation of blood gases and other measurements (performed on the same specimen) | Blood | Anion gap; Base excess; Calcium; Carboxyhaemoglobin; Chloride; Deoxyhaemoglobin (HHb); Glucose; Lactate; Partial pressure of carbon dioxide (pCO2); Partial pressure of oxygen (PO2); Potassium; Sodium; pH |
| Chemical pathology - Quantitation of vitamins | Plasma | 25-Hydroxyvitamin D; Cobalamin (vitamin B12) |
| Chemical pathology - Tests for thyroid function | Plasma | Thyroid stimulating hormone (TSH); Thyroxine (T4) - Free; Triiodothyronine (T3) - Free |
| Immunopathology - Detection and/or quantitation and/or characterisation of autoantibodies | Serum | Anti-thyroid peroxidase antibodies (TPO) |
| Immunopathology - Quantitation of complement proteins | Plasma; Serum | Complement components C3 and C4 |
| Immunopathology - Quantitative investigations of immunoglobulins and immunoglobulins subclasses | Plasma | Immunoglobulin subclasses; Total immunoglobulin A; Total immunoglobulin G; Total immunoglobulin M |
| Infertility and pregnancy tests including assisted reproductive technology - Diagnosis of pregnancy | Plasma | Human chorionic gonadotropin (hCG) |
| Infertility and pregnancy tests including assisted reproductive technology - Diagnosis or follow up of threatened abortion and/or diagnosis of ectopic pregnancy | Plasma | Human chorionic gonadotropin (hCG) - Quantitative total |
| Molecular genetics - Assay for defined mutation or polymorphism (including pharmacogenetic testing) - Targeted genes | Blood | Apolipoprotein E genotyping; Familial defective apoB-100 genotyping |
| Molecular genetics - DNA extraction | Blood; Buffy coat | DNA storage for future analyses; Viable DNA for sequencing and other molecular assays |
| Buccal swabs; Saliva | DNA storage for future analyses; Viable DNA for sequencing and other molecular assays | |
| Molecular genetics - Investigation of constitutional genetic variants - Carrier testing - Targeted genes | Blood | Cardiometabolic gene panel; Familial hyperaldosteronism; Familial hypercholesterolemia; Familial hypertriglyceridaemia; Familial hypocalciuric hypercalcaemia; Maturity onset diabetes of the young (MODY); Rare inherited lipid disorders; Thyroid hormone resistance |
| Molecular genetics - Screening for an unknown mutation - Targeted panels for inherited (germline) DNA/RNA changes | Blood | Familial hyperaldosteronism; Familial hypercholesterolemia; Familial hypertriglyceridaemia; Familial hypocalciuric hypercalcaemia; Maturity onset diabetes of the young (MODY); Rare inherited lipid disorders; Thyroid hormone resistance |
Birth Suite
ISO 15189 (2022)
Human Pathology
Medicare expiry date
04 Aug 2026
Last Activity Date
07 Mar 2024
| Service | Product | Determinant |
|---|---|---|
| Chemical pathology - Quantitation of blood gases and other measurements (performed on the same specimen) | Blood | Anion gap; Base excess; Calcium; Carboxyhaemoglobin; Chloride; Deoxyhaemoglobin (HHb); Glucose; Lactate; Partial pressure of carbon dioxide (pCO2); Partial pressure of oxygen (PO2); Potassium; Sodium; pH |
Cardiothoracic
ISO 15189 (2022)
Human Pathology
Medicare expiry date
04 Aug 2026
Last Activity Date
07 Mar 2024
| Service | Product | Determinant |
|---|---|---|
| Chemical pathology - Quantitation of blood gases and other measurements (performed on the same specimen) | Blood | Anion gap; Base excess; Calcium; Carboxyhaemoglobin; Chloride; Deoxyhaemoglobin (HHb); Glucose; Lactate; Partial pressure of carbon dioxide (pCO2); Partial pressure of oxygen (PO2); Potassium; Sodium; pH |
Diabetic Clinic
ISO 15189 (2022)
Human Pathology
Medicare expiry date
04 Aug 2026
Last Activity Date
07 Mar 2024
| Service | Product | Determinant |
|---|---|---|
| Chemical pathology - Diagnosis and management of diabetes mellitus | Blood | Glycated haemoglobin (HbA1c) |
Emergency Department – Adult
ISO 15189 (2022)
Human Pathology
Medicare expiry date
04 Aug 2026
Last Activity Date
07 Mar 2024
| Service | Product | Determinant |
|---|---|---|
| Chemical pathology - Quantitation of blood gases and other measurements (performed on the same specimen) | Blood | Anion gap; Base excess; Calcium; Carboxyhaemoglobin; Chloride; Deoxyhaemoglobin (HHb); Glucose; Lactate; Partial pressure of carbon dioxide (pCO2); Partial pressure of oxygen (PO2); Potassium; Sodium; pH |
Emergency Department – Paediatric
ISO 15189 (2022)
Human Pathology
Medicare expiry date
04 Aug 2026
Last Activity Date
07 Mar 2024
| Service | Product | Determinant |
|---|---|---|
| Chemical pathology - Quantitation of blood gases and other measurements (performed on the same specimen) | Blood | Anion gap; Base excess; Calcium; Carboxyhaemoglobin; Chloride; Deoxyhaemoglobin (HHb); Glucose; Lactate; Partial pressure of carbon dioxide (pCO2); Partial pressure of oxygen (PO2); Potassium; Sodium; pH |
Haematology
ISO 15189 (2022)
Human Pathology
Medicare expiry date
04 Aug 2026
Last Activity Date
07 Mar 2024
| Service | Product | Determinant |
|---|---|---|
| Cytogenetics - Detection of defined, balanced and/or unbalanced chromosomal abnormalities by in situ hybridisation techniques | Blood; Bone marrow; Other body fluids; Tissues | Cytogenetic analysis and reporting |
| Cytogenetics - Molecular karyotype (SNP microarray) detection of unbalanced chromosome abnormalities | Blood | Chromosomal rearrangement; Cytogenetic analysis and reporting |
| Blood; Bone marrow; Lymph nodes | Chromosomal rearrangement; Cytogenetic analysis and reporting; Karyomapping for known single gene disorders | |
| Haematology - Bone marrow examination | Bone marrow | Examination of aspirated material |
| Haematology - Examination of blood films by special staining | Blood | Microfilaria |
| Malaria | ||
| Urine | Haemosiderin | |
| Haematology - Full blood examination | Blood | Differential number; Erythrocyte count (red blood cell count, RBCC); Haematocrit (packed cell volume, PCV); Haemoglobin (Hb); Leucocyte count (white blood cell count, WBCC); Mean corpuscular haemoglobin (MCH); Mean corpuscular haemoglobin concentration (MCHC); Mean corpuscular volume (MCV); Mean platelet volume (MPV); Nucleated red blood cells (NRBC); Platelet count; Red blood cell distribution width (RDW); Red blood cell index or indices; Reticulocytes |
| Differential number; Morphology | ||
| Haematology - Haemostasis related analysis (including special coagulation testing and platelet function tests) | Blood | Thromboelastometry |
| Plasma | Heparin induced thrombotic thrombocytopenia (HITT) | |
| Thrombin anti-thrombin complex (TAT) | ||
| Platelet function (PFA) | ||
| Activated partial thromboplastin time (APTT); D-dimer; Fibrinogen; International normalised ratio (INR); Prothrombin time (PT); Thrombin time (TT) | ||
| ADAMTS-13 activity | ||
| Platelet aggregation | ||
| Activated partial thromboplastin time (APTT); Anti-Xa - Apixaban; Anti-Xa - Dabigatran; Anti-Xa - Fondaparinux; Anti-Xa - Orgaran; Anti-Xa - Rivaroxaban; Anti-Xa activity; Anti-Xa activity - Unfractionated heparin; Anti-thrombin III; Circulating coagulation factor inhibitors; D-dimer; Emicizumab levels; Factor II; Factor IX; Factor V; Factor VII; Factor VIII; Factor X; Factor XI; Factor XII; Fibrinogen; International normalised ratio (INR); Lupus anticoagulant; Plasminogen; Protein C; Protein C and protein S; Prothrombin time (PT); Reptilase time; Thrombin time (TT); Von Willebrand factor (vWF); Von Willebrand factor (vWF) activity - Ristocetin co-factor assay | ||
| Tissue Plasminogen Activator (tPA) | ||
| Collagen binding activity | ||
| Plasminogen activator inhibitor | ||
| Haematology - Limited blood examination | Blood | Erythrocyte (RBC) sedimentation rate (ESR) |
| Immunohaematology - Blood grouping | Blood | ABO; RhD |
| Immunohaematology - Determination of compatibility of blood donor units | Blood | Direct antiglobulin test (DAT, direct Coombs test); Examination for blood group antibodies; Group checks of patient and donor; Identification of detected antibodies |
| Immunohaematology - Identification and quantitation of blood group antibodies | Blood | Antibody absorption; Antibody elution; Antibody titration; Direct antiglobulin test (DAT, direct Coombs test); Other blood group antibodies; Red blood cell phenotyping; Rh |
| Immunohaematology - Identification of granulocyte antibodies | Blood | Granulocyte specific antibodies |
| Immunohaematology - Identification of platelet antibodies | Blood | Human platelet antigen (HPA) antibodies; Platelet specific antibodies |
| Immunohaematology - Identification of platelet antigens | Blood | Human platelet antigen (HPA) typing; Platelet specific antigens |
| Immunohaematology - Investigation of blood transfusion reactions | Blood; Blood products | Antibodies; Direct antiglobulin test (DAT, direct Coombs test); Examination for blood group antibodies; Group checks of patient and donor; Identification of detected antibodies |
| Immunohaematology - Issue and release of blood and blood product for transfusion | Blood; Blood products; Cryoprecipitate; Fresh frozen plasma (FFP); Platelets | Issue and release of blood and blood products for transfusion |
| Immunohaematology - Storage and distribution of blood and blood components | Blood; Blood products; Cryoprecipitate; Fresh frozen plasma (FFP); Platelets | Compliance with transport, storage and distribution requirements of blood, products and components |
| Immunopathology - Characterisation of leucocyte surface antigens (including immunophenotyping) | Blood; Bone marrow; Fluids; Fresh tissue | CD34; Leukaemia screen; Lymphocyte surface markers; Lymphoma screen; Myeloma screen; Paroxysmal nocturnal haemoglobinuria (PNH) surface markers |
| Microbiology - Parasitology - Detection of ova, cysts and parasites | Blood | Malaria |
| Microbiology - Serology of infection - Microbial antibody and/or antigen detection and/or quantitation | Blood | Infectious mononucleosis |
| Molecular genetics - Assay for defined mutation or polymorphism (including pharmacogenetic testing) - Targeted panels for inherited (germline) DNA/RNA changes | Blood | Factor V Leiden; Nucleic acid analysis for specific variants; Prothrombin variant |
| Red cell antigen genotypingPlatelet antigen genotyping to be added to masterlist. | ||
| Factor V Leiden; Nucleic acid analysis for specific variants; Prothrombin variant | ||
| Molecular genetics - Genetic testing for chimerism and mosaic gene variants (cancer and somatic mosaicism) - Targeted genes | Blood; Bone marrow | Blood borne tumours; Chronic myeloid leukaemia (CML); Lymphoproliferative disorders; Nucleic acid analysis for specific variants |
| Acute myeloid leukaemia RUNX1; Blood borne tumours; Chronic myeloid leukaemia (CML); JAK2 exon 12 mutation; Lymphoproliferative disorders; Nucleic acid analysis for specific variants | ||
| Acute myeloid leukaemia RUNX1; Copy number variation (CNV); Essential thrombocythemia (ET); Myeloproliferative disorders; Myeloproliferative neoplasms; Polycythaemia vera; Primary myelofibrosis; Quantitation of donor and recipient bone marrow derived cells in a transplant recipient | ||
| FLT3-ITD (internal tandem duplication) mutation; FLT3-TKD (tyrosine kinase domain) mutation; Isocitrate dehydrogenase IDH1 and IDH2 mutation analysis; Nucleophosmin 1 (NPM1) mutation | ||
| Molecular genetics - RNA extraction | Blood; Bone marrow | Purified PCR product; RNA storage for future analyses; Viable RNA; Viable RNA for sequencing |
Immunopathology
ISO 15189 (2022)
Human Pathology
Medicare expiry date
04 Aug 2026
Last Activity Date
07 Mar 2024
| Service | Product | Determinant |
|---|---|---|
| Immunopathology - Complete HLA antigen tissue typing | Extracted DNA | HLA class I antigens; HLA class II antigens |
| HLA class I antigens; HLA class II antigens | ||
| Immunopathology - Detection and/or quantitation and/or characterisation of autoantibodies | Biopsy specimens | Anti-pemphigoid antibodies; Anti-pemphigus antibodies |
| Serum | Anti-cardiolipin antibodies (ACA); Anti-cyclic citrullinated peptide antibodies (CCP); Anti-glycoprotein-210 antibodies (GP210); Anti-neutrophil cytoplasmic antibodies - ANCA MPO; Anti-proteinase 3 antibodies (PR3); Anti-tissue transglutaminase antibodies (tTG); Anti-β2-glycoprotein-I antibodies | |
| Anti-nuclear antibodies (ANA) | ||
| Anti-double stranded DNA antibodies (dsDNA) | ||
| Anti-neutrophil cytoplasmic antibodies (ANCA) | ||
| Anti-Jo-1 antibodies; Anti-La antibodies; Anti-Ro-52 antibodies; Anti-Ro-60 antibodies; Anti-Scl-70 antibodies; Anti-Smith antibodies (Sm); Anti-centromere protein B antibodies (Cenp-B); Anti-histone antibodies (AHA); Anti-proliferating cell nuclear antigen (PCNA); Anti-ribonucleoprotein antibodies (RNP); Anti-ribosomal P protein antibodies | ||
| Anti-double stranded DNA antibodies (dsDNA) | ||
| Anti-liver-kidney microsomes antibodies (LKM); Anti-mitochondrial antibodies (AMA, AMA M1 and/or AMA M2); Anti-parietal cell antibodies; Anti-ribosomal P protein antibodies; Anti-smooth muscle antibodies (SMA) | ||
| Anti-extractable nuclear antigen antibodies (ENA) | ||
| Immunopathology - Killer cell immunoglobulin-like receptors (KIR) typing | Blood | Natural killer (NK) cell typing |
| Immunopathology - Leukocyte antibody testing | Blood; Serum | HLA class I antibodies; HLA class II antibodies |
| HLA class I antibodies; HLA class II antibodies | ||
| Crossmatch for transplant recipients | ||
| HLA class I antibodies; HLA class II antibodies | ||
| Immunopathology - Quantitative and/or qualitative investigation of proteins | Plasma; Serum | Cryofibrinogen; Cryoglobulins |
| Immunopathology - Single HLA antigen typing | Extracted DNA | HLA-B1502; HLA-B27; HLA-B5701; HLA-DQ2.2; HLA-DQ2.5; HLA-DQ8; HLA-DRB1 |
| Immunopathology - Tests of cellular immunity - Cytokine assays | Serum | Interferon-γ (IFN-γ) |
| Microbiology - Molecular biology - Microbial genotyping | Plasma | Human immunodeficiency virus type 1 (HIV-1) sequencing for drug resistance |
| Microbiology - Molecular biology - Quantitation of microbial nucleic acids | Plasma | Human immunodeficiency virus (HIV) RNA viral load |
| Molecular genetics - Assay for defined mutation or polymorphism (including pharmacogenetic testing) - Targeted panels for inherited (germline) DNA/RNA changes | Extracted DNA | Periodic fever syndrome |
| Molecular genetics - DNA extraction | Blood; Buffy coat | DNA storage for future analyses; Purified PCR product; Viable DNA for sequencing and other molecular assays |
| Buccal swabs; Dry swabs | DNA storage for future analyses; Purified PCR product; Viable DNA for sequencing and other molecular assays | |
| Buccal swabs; Saliva | DNA storage for future analyses; Purified PCR product; Viable DNA for sequencing and other molecular assays | |
| Molecular genetics - DNA sequencing | Extracted DNA | Sequenced DNA by Sanger sequencing |
Intensive Care Unit
ISO 15189 (2022)
Human Pathology
Medicare expiry date
04 Aug 2026
Last Activity Date
07 Mar 2024
| Service | Product | Determinant |
|---|---|---|
| Chemical pathology - Quantitation of blood gases and other measurements (performed on the same specimen) | Blood | Anion gap; Base excess; Calcium; Carboxyhaemoglobin; Chloride; Deoxyhaemoglobin (HHb); Glucose; Lactate; Partial pressure of carbon dioxide (pCO2); Partial pressure of oxygen (PO2); Potassium; Sodium; pH |
Maternity Nursery
ISO 15189 (2022)
Human Pathology
Medicare expiry date
04 Aug 2026
Last Activity Date
07 Mar 2024
| Service | Product | Determinant |
|---|---|---|
| Chemical pathology - Quantitation of blood gases and other measurements (performed on the same specimen) | Blood | Anion gap; Base excess; Calcium; Carboxyhaemoglobin; Chloride; Deoxyhaemoglobin (HHb); Glucose; Lactate; Partial pressure of carbon dioxide (pCO2); Partial pressure of oxygen (PO2); Potassium; Sodium; pH |
Medical Imaging CT
ISO 15189 (2022)
Human Pathology
Medicare expiry date
04 Aug 2026
Last Activity Date
07 Mar 2024
| Service | Product | Determinant |
|---|---|---|
| Chemical pathology - Investigation and determination of hepatic, cardiac, bone, skeletal muscle and other profiles and metabolic studies | Blood | Creatinine |
Medical Imaging MRI
ISO 15189 (2022)
Human Pathology
Medicare expiry date
04 Aug 2026
Last Activity Date
07 Mar 2024
| Service | Product | Determinant |
|---|---|---|
| Chemical pathology - Investigation and determination of hepatic, cardiac, bone, skeletal muscle and other profiles and metabolic studies | Blood | Creatinine |
Microbiology
ISO 15189 (2022)
Human Pathology
Medicare expiry date
04 Aug 2026
Last Activity Date
07 Mar 2024
| Service | Product | Determinant |
|---|---|---|
| Microbiology - Bacteriology - Detection and identification of crystalline material | Synovial fluid | Crystal detection and identification |
| Microbiology - Bacteriology - Detection of pathogenic bacteria | Aspirates; Biopsy specimens; Blood; Cerebrospinal fluid (CSF); Ear swabs; Eye swabs; Fluids; Genital swabs; Nasal swabs; Pus; Rectal swabs; Respiratory specimens; Skin; Sputum; Synovial fluid; Throat swabs; Urethra; Urine; Wound swabs | Pathogenic identification and antibiotic susceptibility |
| Aspirates; Biopsy specimens; Blood; Cerebrospinal fluid (CSF); Ear swabs; Eye swabs; Fluids; Genital swabs; Nasal swabs; Pus; Rectal swabs; Respiratory specimens; Skin; Sputum; Synovial fluid; Throat swabs; Urethra; Wound swabs | Bacteria; Epithelial cells; Erythrocytes (red blood cells, RBC); Leucocytes (white blood cells, WBC) | |
| Bacterial isolates | Pathogenic identification | |
| Antibiotic susceptibility | ||
| Antibiotic susceptibility | ||
| Pathogenic identification | ||
| Biopsy specimens; Blood; Cerebrospinal fluid (CSF); Fluids; Tissues | Pathogenic identification | |
| Urine | Legionella antigen; Streptococcus pneumoniae antigen | |
| Casts; Crystals; Epithelial cells; Erythrocytes (red blood cells, RBC); Leucocytes (white blood cells, WBC); Red blood cell morphology | ||
| Bilirubin; Blood; Glucose; Ketones; Leucocytes (white blood cells, WBC); Proteins; Specific gravity; Urobilinogen; pH | ||
| Casts; Crystals; Epithelial cells; Erythrocytes (red blood cells, RBC); Leucocytes (white blood cells, WBC); Urinary sediment | ||
| Microbiology - Environmental investigations and/or infection control (Clinical non-human testing) | Environmental swabs; Gastrointestinal endoscopes; Vascular catheter tips | Pathogenic identification and antibiotic susceptibility |
| Non-human clinical isolates | Bacterial organism identification - Acinetobacter; Bacterial organism identification - Legionella spp.; Bacterial organism identification - Carbapenem resistant Enterobacteriaceae (CRE); Bacterial organism identification - Extended spectrum β-lactamases (ESBL); Bacterial organism identification - Metallo-β-lactamase (MBL) carbapenemase; Bacterial organism identification - Methicillin-resistant Staphylococcus aureus (MRSA); Bacterial organism identification - Vancomycin-resistant Enterococcus (VRE); Yeast organism identification - Candida auris | |
| Spore strips | Bacterial growth - Sterility | |
| Microbiology - Molecular biology - Detection, characterisation and/or quantitation of microbial nucleic acids (bacteria) | Bacterial isolates; Blood; Cerebrospinal fluid (CSF); Faeces; Genital swabs; Plasma; Rectal swabs; Respiratory specimens; Serum; Sputum; Tissues; Urine | Staphylococcus aureus; MecA gene; Methicillin resistant Staphylococcus aureus (MRSA); Nuc gene; Panton-Valentine leukocidin gene (PVL); Van A/B/C gene |
| Bacterial isolates; Faeces; Genital swabs; Rectal swabs; Respiratory specimens; Sputum; Tissues; Urine | Chlamydia trachomatis; Clostridioides difficile; Neisseria gonorrhoeae | |
| Bacterial isolates; Fluids; Tissues | Microbial identification | |
| Bacterial isolates; Genital swabs; Rectal swabs | Neisseria gonorrhoeae gyrA | |
| Bacterial isolates; Respiratory specimens; Sputum | Legionella pneumophila | |
| Faeces | Campylobacter spp.; Escherichia coli - Enteroinvasive (EIEC); Escherichia coli - Enterotoxigenic (ETEC); Escherichia coli; Escherichia coli STEC stx1/stx2; Plesiomonas shigelloides; Salmonella spp.; Shigella spp.; Vibrio spp.; Yersinia enterocolitica | |
| Fluids; Genital swabs; Tissues | Treponema pallidum | |
| Nasal swabs; Nasopharyngeal swabs | Bordetella bronchiseptica; Bordetella parapertussis; Bordetella pertussis; Chlamydophila pneumoniae; Mycoplasma pneumoniae | |
| Microbiology - Molecular biology - Detection, characterisation and/or quantitation of microbial nucleic acids (fungi) | Fluids; Isolates; Tissues | Fungi identification; Yeasts identification |
| Respiratory specimens | Pneumocystis jirovecii | |
| Microbiology - Molecular biology - Detection, characterisation and/or quantitation of microbial nucleic acids (mycobacteria) | Bronchial washings; Sputum | Mycobacterium tuberculosis |
| Microbiology - Molecular biology - Detection, characterisation and/or quantitation of microbial nucleic acids (protozoan parasites) | Faeces | Cryptosporidium hominis; Cryptosporidium parvum; Cryptosporidium spp.; Entamoeba histolytica; Giardia intestinalis |
| Microbiology - Molecular biology - Detection, characterisation and/or quantitation of microbial nucleic acids (viruses) | Bronchial washings; Bronchoalveolar lavage; Cell culture; Cerebrospinal fluid (CSF); General swabs; Genital swabs; Isolates; Mucus smears; Plasma; Respiratory specimens; Serum; Urine | Adenovirus; BK virus; Cytomegalovirus (CMV); Epstein-Barr virus; Hepatitis B virus (HBV) DNA; Hepatitis C virus (HCV) viral RNA; Hepatitis C virus (HCV) genotypes 1-6 and subtypes; Herpes simplex virus (HSV); Human immunodeficiency virus (HIV) DNA; Varicella zoster virus (VZV) |
| Bronchoalveolar lavage; Endotrachael aspirate; Nasal swabs; Nasopharyngeal aspirate; Nasopharyngeal swabs; Throat swabs | Adenovirus; Human metapneumovirus; Influenza A virus; Influenza B virus; Parainfluenza virus type 1/2/3/4; Respiratory syncytial virus (RSV); Rhinovirus | |
| Cadaveric donor plasma; Cadaveric donor serum | Hepatitis B virus (HBV) DNA; Hepatitis C virus (HCV) viral RNA; Human immunodeficiency virus type 1 (HIV-1) RNA; Human immunodeficiency virus type 2 (HIV-2) RNA | |
| Faeces | Adenovirus F40; Adenovirus F41; Arbovirus; Astrovirus; Norovirus G1; Norovirus G2; Rotavirus A; Sapovirus I; Sapovirus II; Sapovirus IV; Sapovirus V | |
| Fluids; Genital swabs; Tissues | Herpes simplex virus type 1 (HSV1); Herpes simplex virus type 2 (HSV2); Varicella zoster virus (VZV) | |
| Liquid based cytology specimens | Human papilloma virus (HPV) | |
| Nasal aspirates/washes; Nasal swabs; Nasopharyngeal swabs; Oropharyngeal swabs | Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2, COVID) | |
| Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2, COVID) | ||
| Nasal swabs; Nasopharyngeal swabs | Adenovirus; Enterovirus; Human coronavirus NL63; Human coronavirus 229E; Human coronavirus HKU1; Human coronavirus OC43; Human immunodeficiency virus type 2 (HIV-2) RNA; Human metapneumovirus; Influenza A virus H1; Influenza A virus H1 - 2009 pandemic strain; Influenza A virus H3; Influenza B virus; Parainfluenza virus type 1/2/3/4; Respiratory syncytial virus (RSV); Rhinovirus; Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2, COVID); Middle Eastern respiratory syndrome coronavirus (MERS-CoV) | |
| Nasal swabs; Nasopharyngeal swabs; Oropharyngeal swabs | Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2, COVID) | |
| Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2, COVID) | ||
| Nasopharyngeal swabs | Influenza A virus; Influenza B virus; Respiratory syncytial virus (RSV) | |
| Microbiology - Mycobacteriology - Detection and identification of mycobacteria | Sputum; Tissues | Mycobacteria detection |
| Microbiology - Mycology - Detection of dermatophytes and other fungi causing cutaneous disease | Hair; Nails; Skin; Skin scrapings | Dermatophyte identification |
| Dermatophyte identification | ||
| Microbiology - Mycology - Detection, isolation and/or identification of yeasts and/or fungal elements | Cerebrospinal fluid (CSF); Fluids; General swabs; Respiratory specimens | Fungi identification; Yeasts identification |
| Fungi identification; Yeasts identification | ||
| Cerebrospinal fluid (CSF); Serum | Cryptococcus antigen | |
| Isolates | Fungi susceptibility; Yeast susceptibility | |
| Fungi identification; Yeasts identification | ||
| Microbiology - Serology of infection - Microbial antibody and/or antigen detection and/or quantitation | Bronchoalveolar lavage; Serum | Aspergillus galactomannan antigen |
| Plasma; Serum | Epstein-Barr virus IgG antibody; Epstein-Barr virus nuclear antigen IgM antibody | |
| Epstein-Barr virus IgM heterophile antibody | ||
| Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) nucleocapsid IgG antibody; Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike IgG antibody; Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2, COVID) IgG antibody | ||
| Serum | Herpes simplex virus type 2 antibody (anti-HSV2) - IgG; Herpes simplex type 1 antibody (anti-HSV1) - IgG; Measles virus; Measles IgG antibody; Mumps virus; Mumps virus IgG antibody; Varicella zoster virus (VZV); Varicella zoster virus (VZV) IgG antibody | |
| Cytomegalovirus antibody (anti-CMV) IgG; Cytomegalovirus antibody (anti-CMV) IgM; Hepatitis A virus antibody (anti-HAV) - IgG; Hepatitis A virus antibody (anti-HAV) - IgM; Hepatitis B virus core antibody (anti-HBc) - IgM; Hepatitis B virus core antibody (anti-HBc) - Total; Hepatitis B virus envelope antibody (anti-HBe); Hepatitis B virus envelope antigen (HBe Ag); Hepatitis B virus surface antibody (anti-HBs); Hepatitis B virus surface antigen (HBs Ag); Hepatitis B virus surface antigen (HBs Ag) - Confirmatory; Hepatitis C virus (HCV); Human immunodeficiency virus type 1/2 (HIV-1/2) 1/2 antibodies; Human immunodeficiency virus type 1/2 (HIV-1/2) antigen; Rubella IgG antibody; Syphilis Treponema pallidum antibody | ||
| Syphilis Treponema pallidum antibody | ||
| Human immunodeficiency virus (HIV) p24 antigen; Human immunodeficiency virus type 1/2 (HIV-1/2) 1/2 antibodies; Human immunodeficiency virus type 1/2 (HIV-1/2) antigen |
Neonatal Unit
ISO 15189 (2022)
Human Pathology
Medicare expiry date
04 Aug 2026
Last Activity Date
07 Mar 2024
| Service | Product | Determinant |
|---|---|---|
| Chemical pathology - Quantitation of blood gases and other measurements (performed on the same specimen) | Blood | Anion gap; Base excess; Calcium; Carboxyhaemoglobin; Chloride; Deoxyhaemoglobin (HHb); Glucose; Lactate; Partial pressure of carbon dioxide (pCO2); Partial pressure of oxygen (PO2); Potassium; Sodium; pH |
Recovery Department
ISO 15189 (2022)
Human Pathology
Medicare expiry date
04 Aug 2026
Last Activity Date
07 Mar 2024
| Service | Product | Determinant |
|---|---|---|
| Chemical pathology - Quantitation of blood gases and other measurements (performed on the same specimen) | Blood | Anion gap; Base excess; Calcium; Carboxyhaemoglobin; Chloride; Deoxyhaemoglobin (HHb); Glucose; Lactate; Partial pressure of carbon dioxide (pCO2); Partial pressure of oxygen (PO2); Potassium; Sodium; pH |
Respiratory Unit
ISO 15189 (2022)
Human Pathology
Medicare expiry date
04 Aug 2026
Last Activity Date
07 Mar 2024
| Service | Product | Determinant |
|---|---|---|
| Chemical pathology - Quantitation of blood gases and other measurements (performed on the same specimen) | Blood | Anion gap; Base excess; Calcium; Carboxyhaemoglobin; Chloride; Deoxyhaemoglobin (HHb); Glucose; Lactate; Partial pressure of carbon dioxide (pCO2); Partial pressure of oxygen (PO2); Potassium; Sodium; pH |
Special Chemistry
ISO 15189 (2022)
Human Pathology
Medicare expiry date
04 Aug 2026
Last Activity Date
07 Mar 2024
| Service | Product | Determinant |
|---|---|---|
| Chemical pathology - Analysis of calculus | Calculi | Ammonium; Calcium; Cysteine; Magnesium; Oxalate; Phosphate; Urate |
| Chemical pathology - Biogenic amines | Blood | Serotonin |
| Blood; Urine | 3-Methoxytyramine; Adrenaline; Dopamine; Metanephrine; Noradrenaline; Normetanephrine | |
| Plasma | 3-Methoxytyramine - Free; Metanephrine - Free; Normetanephrine - Free | |
| Urine | 5-Hydroxyindoleacetic acid (5-HIAA); Homovanillic acid (HVA); Hydroxymethoxymandelic acid (HMMA) | |
| Chemical pathology - Detection and/or quantitation of drugs for therapeutic monitoring | Plasma; Serum | Benzylpenicillin; Flucloxacillin; Sulfamethoxazole |
| Chemical pathology - Detection and/or quantitation of tumour markers | Plasma; Serum | Chromogranin A - Gen II |
| Neuron specific enolase (NSE) | ||
| Plasma; Serum; Urine | β2-Microglobulin (B2M) | |
| Chemical pathology - Determination of hormones and hormone binding proteins (other than thyroid function tests) | Plasma | Aldosterone; Insulin-like growth factor 1 (IGF-1, somatomedin C); Renin |
| Aldosterone; Cortisol | ||
| Plasma; Serum | 17α-Hydroxyprogesterone; Androstenedione; Testosterone | |
| Adrenocorticotropic hormone (ACTH); Calcitonin; Dehydroepiandrosterone sulfate (DHEAS); Erythropoietin (EPO); Gastrin; Growth hormone; Insulin-like growth factor-binding protein 3 (IGF-BP3); Sex hormone binding globulin (SHBG) | ||
| Saliva | Cortisol | |
| Serum | Anti-Mullerian hormone (AMH) | |
| Urine | 11-Deoxycortisol; Cortisol - Free | |
| Chemical pathology - Further investigation of cardiac function | Blood | N-Terminal-pro b-type natriuretic peptide (NT-proBNP) |
| Plasma; Serum | Troponin T | |
| Chemical pathology - Markers of bone metabolism | Plasma | Procollagen type 1 N-terminal propeptide (P1NP); c-Telopeptide (CTx) |
| Chemical pathology - Quantitation of precursor and intermediary metabolites | Urine | Citrate; Oxalate |
| Chemical pathology - Quantitation of vitamins | Plasma; Serum | Pyridoxine (vitamin B6, pyridoxal, pyridoxamine); Thiamine (vitamin B1) |
| 25-Hydroxyvitamin D3 | ||
| Chemical pathology - Tests for thyroid function | Plasma; Serum | Thyroid stimulation immunoglobulins |
| Immunopathology - Quantitative and/or qualitative investigation of proteins | Cerebrospinal fluid (CSF); Serum | Characterisation of paraproteins; Detection and amount of paraproteins; Detection of Bence Jones proteins; Elastase; Immunoglobulin G (IgG) - Kappa; Immunoglobulin G (IgG) - Lambda; Protein classes |
| Faeces | Calprotectin; Pancreatic elastase |
Stem Cell Transplant Laboratory
ISO 15189 (2022)
Human Pathology
Medicare expiry date
04 Aug 2026
Last Activity Date
07 Mar 2024
| Service | Product | Determinant |
|---|---|---|
| Immunopathology - Procedures related to the collection, processing, storage and issue of human haemopoietic progenitor cellsAllogenic processing; Autologous processing; Products received from AN 19815 SN 23122 | Haemopoietic progenitor cells | Clonogenic assays (culture) of harvested bone marrow/peripheral blood progenitor cells/cord blood stem cells; Enumeration of CD34+ cells; Processing; Storage (includes freezing/thawing); Total leucocyte number |
Theatres
ISO 15189 (2022)
Human Pathology
Medicare expiry date
04 Aug 2026
Last Activity Date
07 Mar 2024
| Service | Product | Determinant |
|---|---|---|
| Chemical pathology - Quantitation of blood gases and other measurements (performed on the same specimen) | Blood | Anion gap; Base excess; Calcium; Carboxyhaemoglobin; Chloride; Deoxyhaemoglobin (HHb); Glucose; Lactate; Partial pressure of carbon dioxide (pCO2); Partial pressure of oxygen (PO2); Potassium; Sodium; pH |
The only data displayed is that deemed relevant and necessary for the clear description of the activities and services covered by the scope of accreditation.
Grey text appearing in a SoA is additional freetext providing further refinement or information on the data in the preceding line entry.
Accreditation No.
2392
Site No.
22309
Print date
26 Nov 2024
END OF SCOPE